首页> Heliyon> Response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis with the N1303K mutation: Case report and review of the literature.

Response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis with the N1303K mutation: Case report and review of the literature.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maria G,Tupayachi Ortiz

第一单位： Division of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, 1951 NW 7th Ave, Suite 2278, Miami, FL, 33136, United States.

作者： Maria G,Tupayachi Ortiz ^[1] ; Nathalie,Baumlin ^[2] ; Makoto,Yoshida ^[2] ; Matthias,Salathe ^[2]

作者单位： Division of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, 1951 NW 7th Ave, Suite 2278, Miami, FL, 33136, United States. ^[1] Department of Internal Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, United States. ^[2]

关键词 Advanced cystic fibrosis lung disease Case report Cystic fibrosis Elexacaftor/Tezacaftor/Ivacaftor N1303K

DOI 10.1016/j.heliyon.2024.e26955

PMID 38463894

发布时间 2024-03-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Heliyon

2024年10卷5期

e26955页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Heliyon

2024年10卷5期

e26955页

检索历史清除

Response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis with the N1303K mutation: Case report and review of the literature.

Heliyon

相似文献

同项目论文

Heliyon

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis with the N1303K mutation: Case report and review of the literature.

Heliyon

相似文献

同项目论文

Heliyon

相关期刊

检索历史清除